BCL11A controls the expression of fetal hemoglobin;BCL11A contrôle l'expression de l'hémoglobine fœtale

Medecine/Sciences

Volumn 28, Issue 11, 2012, Pages 923-925

  Labie, Dominique ^a  

^a INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BCL11A PROTEIN, HUMAN; CARRIER PROTEIN; ERYTHROID KRUPPEL LIKE FACTOR; ERYTHROID KRUPPEL-LIKE FACTOR; HEMOGLOBIN BETA CHAIN; HEMOGLOBIN F; HEMOGLOBIN GAMMA CHAIN; KRUPPEL LIKE FACTOR; NUCLEAR PROTEIN; SMALL INTERFERING RNA;

ANIMAL; ARTICLE; BIOSYNTHESIS; CHROMOSOME 2; CHROMOSOME 6; DISEASE MODEL; ERYTHROID PRECURSOR CELL; GENE EXPRESSION REGULATION; GENE THERAPY; GENETICS; HUMAN; INTRON; METABOLISM; MOLECULARLY TARGETED THERAPY; MOUSE; MOUSE MUTANT; PHYSIOLOGY; RNA INTERFERENCE; SICKLE CELL ANEMIA; TRANSGENIC MOUSE;

ANEMIA, SICKLE CELL; ANIMALS; BETA-GLOBINS; CARRIER PROTEINS; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 6; DISEASE MODELS, ANIMAL; ERYTHROID PRECURSOR CELLS; FETAL HEMOGLOBIN; GAMMA-GLOBINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC THERAPY; HUMANS; INTRONS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MOLECULAR TARGETED THERAPY; NUCLEAR PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84871654924     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/20122811007     Document Type: Article

References (12)

1. Lettre G, Sankaran VG, Bezerra M A C, et al. DNA polymorphisms at the BCL11A, HBS1L-MYB and β-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Nat Acad Sci USA 2008;105:11869-74.
2. Gγ expression. Blood 1985;66:1463-5.
3. Neishabury M, Zamani S, Azarkeivan A, et al. The modifying effect of Xmn1-HBG2 on thalassemic phenotype is associated with its linked elements in the beta globin locus control region, including the palindromic site at 5'HS4. Blood Cells Mol Dis 2012;48:1-5.
4. Sankaran VG, Menne TF, Xu J, et al. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science 2008;322:1839-42.
5. Sankaran VG, Xu J, Ragoczy T, et al. Developmental and species-divergent globin switching are driven by BCL11A. Nature 2009;460:1093-7.
6. Thein SL, Menzel S, Peng X et al. Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults. Proc Nat Acad Sci USA 2007;104:11346-51. (Pubitemid 47175143)
7. Wahlberg K, Jiang J, Rooks H, et al. The HSB1L-MYB intergenic interval associated with elevated HbF levels shows characteristics of a distal regulatory region in erythroid cells. Blood 2009;114:1254-62.
8. Borg J, Papadopoulos P, Georgitsi M, et al. Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin. Nat Genet 2010;42:501-5.
9. Zhou D, Liu K, Sun CW, et al. KLF1 regulates BCL11A expression andy-to P-globin gene switching. Nat Genet 2010;42:742-4.
10. Galarneau G, Palmer CD, Sankaran VG, et al. Fine-mapping at three loci known to affect fetal hemoglobin levels explain additional genetic variation. Nat Genet 2010;42:1049-51.
11. Xu J, Sankaran VG, Ni M, et al. Transcriptional silencing of y-globin by BCL11A involves long-range interactions and cooperation with SOX. Genes Dev 2010;24:783-98.
12. Xu J, Peng C, Sankaran VG, et al. Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing. Science 2011;334:993-6.